综述:经典铋剂四联疗法根除幽门螺杆菌的临床实践问题
本文综述经典铋剂四联疗法(PPI+铋剂+四环素+甲硝唑)在幽门螺杆菌感染中的疗效、安全性与优化策略。BQT在耐药背景下仍保持高效,双倍剂量PPI每日两次可最大化疗效;单胶囊制剂简化给药且根除率>90%。BQT被多数国际指南推荐为一线治疗,尤其适用于克拉霉素耐药率>15%地区。
要点
- 经典BQT是幽门螺杆菌根除的基石方案,耐药背景下仍保持高效。
- 双倍剂量PPI每日两次可最大化BQT疗效。
核心结论
- 经典铋剂四联疗法仍是幽门螺杆菌根除最有效、安全且实用的方案,在多种耐药模式和临床情境下保证高治愈率。
研究设计与样本
- 综述类文章,通过全面文献检索纳入评估BQT疗效、安全性和优化策略的研究。
主要发现
- BQT联合互补作用机制药物,在抗生素耐药情况下仍保持高效。
- 双倍剂量PPI每日两次可最大化治疗成功。
- 四环素不可及时米诺环素可作替代,多西环素因疗效较低不推荐。
- 三合一单胶囊制剂简化给药、提高依从性并保持>90%高效。
关键数值与推荐
- BQT被多数国际指南推荐为一线治疗,尤其克拉霉素耐药率>15%地区。
- BQT是克拉霉素或氟喹诺酮方案失败后最可靠的补救选择。
- BQT是青霉素过敏患者的首选治疗。
- 单胶囊制剂根除率>90%。
临床怎么用
- 临床可优先选择经典BQT作为一线或补救治疗,尤其在高克拉霉素耐药地区和青霉素过敏患者中。
- 采用双倍剂量PPI每日两次以优化抑酸,提高根除成功率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Classic bismuth quadruple therapy (BQT)-the combination of a proton pump inhibitor, bismuth, tetracycline, and metronidazole-is a standard regimen for treating Helicobacter pylori infection. AIMS: This review addresses practical questions regarding its current role in managing the infection. METHODS: A comprehensive bibliographic search was conducted to identify studies evaluating the efficacy, safety and optimization of BQT in different clinical contexts. RESULTS: BQT is a cornerstone of H. pylori eradication, combining agents with complementary mechanisms of action and maintaining high efficacy even in the presence of antibiotic resistance. Optimal acid suppression with a double proton pump inhibitor dose twice daily maximises therapeutic success. When tetracycline is unavailable, minocycline may serve as an alternative, whereas doxycycline is not recommended due to lower efficacy. Ten-day regimens achieve eradication rates comparable to 14-day courses, with similar or better tolerability. The three-in-one single-capsule formulation simplifies administration, enhances adherence, and maintains high efficacy (> 90%). BQT is endorsed as first-line therapy in most international guidelines, particularly in regions with clarithromycin resistance exceeding 15%, and remains the most reliable rescue option after failure of clarithromycin- or fluoroquinolone-based regimens. It is also the treatment of choice for patients with penicillin allergy. The regimen is generally well tolerated, with mostly mild, transient and gastrointestinal adverse events. CONCLUSIONS: BQT remains the most effective, safe, and practical regimen for H. pylori eradication, ensuring high cure rates across diverse resistance patterns and clinical settings. Simplified formulations further improve convenience and adherence, reinforcing its role as a globally applicable therapy.
引用
- Gisbert JP, Parra P, Nyssen OP, et al. Review Article: Classic Bismuth Quadruple Therapy for Helicobacter pylori Infection-Questions Focused on Clinical Practice. Aliment Pharmacol Ther. 2026. PMID: 41549833. doi:10.1111/apt.70535
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。